Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Deciphera Pharmaceuticals, Inc. (DCPH)  
$25.36 0.01 (0.04%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 60,930,000
Market Cap: 1.55(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $10.11 - $25.38
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Deciphera Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to improve the lives of people with cancer. QINLOCK, Co.'s switch-control kinase inhibitor, was developed using Co.'s proprietary drug discovery platform and developed for the treatment of fourth-line gastrointestinal stromal tumor. In addition, Co. has identified and developed various product candidates from its platform into clinical studies, including vimseltinib and DCC-3116. Co. is studying vimseltinib in a Phase 3 study in patients with tenosynovial giant cell tumor. DCC-3116 is designed to inhibit autophagy, a key tumor survival mechanism in cancer cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 10,000 1,687,666
Total Buy Value $0 $0 $138,828 $30,291,232
Total People Bought 0 0 1 3
Total Buy Transactions 0 0 1 3
Total Shares Sold 10,159 75,715 115,161 179,650
Total Sell Value $158,659 $1,108,986 $1,602,723 $2,646,007
Total People Sold 4 5 6 6
Total Sell Transactions 4 14 25 43
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 290
  Page 7 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Taylor Michael Douglas Director   –       •      –    2020-04-28 4 OE $1.89 $47,250 D/D 25,000 25,000     -
   Hoerter Steven L. President and CEO   •       •      –    2020-04-21 4 OE $25.40 $4,750 D/D 187 42,017     -
   Taylor Michael Douglas Director   –       •      –    2020-04-17 4 AS $46.67 $1,115,150 D/D (23,892) 0 -6%     
   Taylor Michael Douglas Director   –       •      –    2020-04-17 4 OE $1.89 $45,156 D/D 23,892 23,892     -
   Taylor Michael Douglas Director   –       •      –    2020-04-14 4 AS $46.71 $51,753 D/D (1,108) 0 1%     
   Taylor Michael Douglas Director   –       •      –    2020-04-14 4 OE $1.89 $2,094 D/D 1,108 1,108     -
   Bristol James Arthur Director   –       •      –    2020-04-09 4 AS $42.97 $1,031,840 D/D (23,542) 0 2%     
   Bristol James Arthur Director   –       •      –    2020-04-09 4 OE $1.89 $44,494 D/D 23,542 23,542     -
   Taylor Michael Douglas Director   –       •      –    2020-04-01 4 AS $37.29 $2,817,558 D/D (75,000) 0 6%     
   Taylor Michael Douglas Director   –       •      –    2020-04-01 4 OE $1.89 $141,750 D/D 75,000 75,000     -
   Hoerter Steven L. President and CEO   •       •      –    2020-03-19 4 D $35.78 $465,619 D/D (12,420) 41,830     -
   Hoerter Steven L. President and CEO   •       •      –    2020-03-18 4 OE $25.40 $57,150 D/D 2,250 54,250     -
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2020-02-18 4 A $0.00 $0 D/D 1,760 36,760     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2020-02-18 4 A $0.00 $0 D/D 7,040 7,040     -
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2020-02-18 4 A $0.00 $0 D/D 7,040 98,446     -
   Allen Patricia L Director   –       •      –    2020-01-24 4 AS $65.93 $1,653,325 D/D (25,000) 0 -19%     
   Allen Patricia L Director   –       •      –    2020-01-24 4 OE $3.95 $98,750 D/D 25,000 25,000     -
   Martin Daniel C. Chief Commercial Officer   •       –      –    2020-01-22 4 AS $67.18 $1,813,709 D/D (26,999) 17,000 -11%     
   Martin Daniel C. Chief Commercial Officer   •       –      –    2020-01-22 4 OE $36.10 $974,664 D/D 26,999 43,999     -
   Morl Christopher John Chief Business Officer   •       –      –    2020-01-16 4 AS $65.40 $196,932 D/D (3,011) 0 -13%     
   Morl Christopher John Chief Business Officer   •       –      –    2020-01-16 4 OE $3.95 $11,893 D/D 3,011 3,011     -
   Morl Christopher John Chief Business Officer   •       –      –    2020-01-15 4 AS $65.23 $784,274 D/D (12,023) 0 -10%     
   Morl Christopher John Chief Business Officer   •       –      –    2020-01-15 4 OE $3.95 $47,491 D/D 12,023 12,023     -
   Morl Christopher John Chief Business Officer   •       –      –    2020-01-08 4 AS $60.12 $738,272 D/D (12,281) 0 -19%     
   Morl Christopher John Chief Business Officer   •       –      –    2020-01-08 4 OE $3.95 $48,510 D/D 12,281 12,281     -
  290 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us